Impact of Surgical Strategy on Perioperative Outcomes, Time to Adjuvant Chemotherapy, and Quality of Life in Malignant Colon Obstruction: A Nationwide Prospective Multicenter Cohort Study

Background. Malignant colon obstruction is a surgical emergency, and the operating surgeon often has to choose an operative strategy quickly under unfavourable physiological conditions. Whether the choice between primary anastomosis, resection with stoma, combined anastomosis with diverting stoma, or diverting stoma alone influences perioperative outcomes and the interval to adjuvant chemotherapy is still unclear. We addressed these questions in a national prospective cohort and also followed health-related quality of life (HRQoL) over the first postoperative year. Methods. Patients undergoing surgery for malignant colon obstruction were enrolled across 13 tertiary centers in Türkiye (NCT05429060). Standardized perioperative data were collected, and HRQoL was assessed with the EORTC QLQ-CR29 instrument preoperatively and at 3 and 12 months. Outcomes were compared across the four surgical strategies using one-way ANOVA for continuous variables and the χ² or Fisher–Freeman–Halton exact test for categorical variables. Time to chemotherapy was analyzed both as a continuous variable and dichotomized at a 30-day threshold. Results. Of 174 patients enrolled, 165 met inclusion criteria (mean age 65.4 ± 13.1 years; 54.5% male). Resection with primary anastomosis was most common (50.3%), followed by resection with stoma (24.8%), combined anastomosis with stoma (13.3%), and diverting stoma without resection (11.5%). Advanced-disease markers—metastasis, perforation, carcinomatosis, and peritonitis—were significantly more frequent in the diverting-stoma and resection-with-stoma groups (all p ≤ 0.012). Operation time differed markedly across techniques (84.7 to 207.6 minutes; p < 0.001), whereas postoperative complications (35.2% overall), reoperation (6.1%), and early mortality (9.7%) did not differ significantly. Adjuvant chemotherapy was initiated in 68.5% of patients at a mean of 29.1 ± 15.8 days; neither the mean interval (p = 0.194) nor the rate of delay beyond 30 days (p = 0.646) differed by surgical strategy. HRQoL scores improved from baseline to 12 months across symptom and functional domains, without significant between-technique differences at any timepoint. Conclusions. In malignant colon obstruction, the surgical strategy reflects disease severity and operative complexity, but is not independently associated with the timing of adjuvant chemotherapy or with medium-term quality of life. Diverting stoma without resection was linked to numerically earlier chemotherapy, most likely because of the lower physiological burden rather than a causal advantage. Individualised decision-making and close multidisciplinary coordination remain central to optimising outcomes. Trial registration ClinicalTrials.gov NCT05429060.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11354713/v1
Primary Topic
Colorectal Cancer Surgical Treatments
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Impact of Surgical Strategy on Perioperative Outcomes, Time to Adjuvant Chemotherapy, and Quality of Life in Malignant Colon Obstruction: A Nationwide Prospective Multicenter Cohort Study

Semra Salimoğlu, Murat Çakır, Hakan Yırgın, Osman Ci̇vil et al.
Research Square
Colorectal Cancer Surgical Treatments
preprint

Impact of Surgical Strategy on Perioperative Outcomes, Time to Adjuvant Chemotherapy, and Quality of Life in Malignant Colon Obstruction: A Nationwide Prospective Multicenter Cohort Study

Semra Salimoğlu, Murat Çakır, Hakan Yırgın, Osman Ci̇vil, Erkan Somuncu, Erdinç Kamer, Mustafa Öncel, İlknur Turan, Metin Kement, Tayfun Kaya, Ercan Gedik, Kıvılcım Ulusan, Fevzi Cengız, Nihat Buğdaycı, Mustafa Celalettin Haksal, Naci̇ye Çiğdem Arslan, Ufuk Oğuz İdiz, Ensar Çakır, Erkan Yavuz, Yusuf Bilgin, Aytaç Emre Kocaoğlu, Hüseyin Esin, Nurhilal Kızıltoprak, Alp Ömer Cantürk, Levent Uğurlu, Serhat Meriç, Berkay Özcan, Ömer Faruk Özkan, Mehmet Karahan, Abdulkadir Akbaş, Selçuk Kaya, Noyan Ilhan, Mehmet Ali Gök, Rozan Kaya, Atıf Tekin, YUNUS EMRE ALTUNTAŞ, Hakan Kul, Mert Mahsuni Sevinç
preprint en

Abstract

Background. Malignant colon obstruction is a surgical emergency, and the operating surgeon often has to choose an operative strategy quickly under unfavourable physiological conditions. Whether the choice between primary anastomosis, resection with stoma, combined anastomosis with diverting stoma, or diverting stoma alone influences perioperative outcomes and the interval to adjuvant chemotherapy is still unclear. We addressed these questions in a national prospective cohort and also followed health-related quality of life (HRQoL) over the first postoperative year. Methods. Patients undergoing surgery for malignant colon obstruction were enrolled across 13 tertiary centers in Türkiye (NCT05429060). Standardized perioperative data were collected, and HRQoL was assessed with the EORTC QLQ-CR29 instrument preoperatively and at 3 and 12 months. Outcomes were compared across the four surgical strategies using one-way ANOVA for continuous variables and the χ² or Fisher–Freeman–Halton exact test for categorical variables. Time to chemotherapy was analyzed both as a continuous variable and dichotomized at a 30-day threshold. Results. Of 174 patients enrolled, 165 met inclusion criteria (mean age 65.4 ± 13.1 years; 54.5% male). Resection with primary anastomosis was most common (50.3%), followed by resection with stoma (24.8%), combined anastomosis with stoma (13.3%), and diverting stoma without resection (11.5%). Advanced-disease markers—metastasis, perforation, carcinomatosis, and peritonitis—were significantly more frequent in the diverting-stoma and resection-with-stoma groups (all p ≤ 0.012). Operation time differed markedly across techniques (84.7 to 207.6 minutes; p < 0.001), whereas postoperative complications (35.2% overall), reoperation (6.1%), and early mortality (9.7%) did not differ significantly. Adjuvant chemotherapy was initiated in 68.5% of patients at a mean of 29.1 ± 15.8 days; neither the mean interval (p = 0.194) nor the rate of delay beyond 30 days (p = 0.646) differed by surgical strategy. HRQoL scores improved from baseline to 12 months across symptom and functional domains, without significant between-technique differences at any timepoint. Conclusions. In malignant colon obstruction, the surgical strategy reflects disease severity and operative complexity, but is not independently associated with the timing of adjuvant chemotherapy or with medium-term quality of life. Diverting stoma without resection was linked to numerically earlier chemotherapy, most likely because of the lower physiological burden rather than a causal advantage. Individualised decision-making and close multidisciplinary coordination remain central to optimising outcomes. Trial registration ClinicalTrials.gov NCT05429060.

Research Square
Dicle University (TR), Izmir Kâtip Çelebi University (TR), Istanbul Medipol University (TR), İstanbul Eğitim ve Araştırma Hastanesi (TR), Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi (TR), Necmettin Erbakan University (TR), Ümraniye Eğitim ve Araştırma Hastanesi (TR), Bağcılar Eğitim ve Araştırma Hastanesi (TR), Izmir Tepecik Eğitim ve Araştırma Hastanesi (TR), İstanbul Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi (TR)
Colorectal Cancer Surgical Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon